Respiratory stimulation with intravenous doxapram in respiratory failure. A double-blind co-operative study.
D000328:Adult; D000368:Aged; D002245:Carbon Dioxide / Q000097:blood; D002986:Clinical Trials as Topic; D004315:Doxapram / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D008173:Lung Diseases, Obstructive / Q000150:complications; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects; D010919:Placebos; D012119:Respiration / Q000187:drug effects*; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D013268:Stimulation, Chemical
D010919:Placebos; D002245:Carbon Dioxide; D004315:Doxapram; D010100:Oxygen